The Scotts Miracle-Gro Company
SMG
$65.38
-3.54%
The Scotts Miracle-Gro Company is the dominant purveyor of home lawn and gardening products in the United States, operating within the Agricultural Inputs industry. The company's competitive identity is defined by its portfolio of well-recognized consumer brands, including Scotts, Miracle-Gro, and Ortho, which cement its position as a market leader in the North American consumer lawn and garden sector. The current investor narrative is heavily focused on the company's strategic refocus on its core consumer business, highlighted by the recent divestiture of its Hawthorne Gardening subsidiary, which signals a move to simplify operations and potentially improve financial stability amidst ongoing debates about its debt-heavy balance sheet and seasonal profitability challenges.…
SMG
The Scotts Miracle-Gro Company
$65.38
Related headlines
SMG 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Scotts Miracle-Gro Company's 12-month outlook, with a consensus price target around $84.99 and implied upside of +30.0% versus the current price.
Average Target
$84.99
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$52 - $85
Analyst target range
Analyst coverage for SMG is limited, with only 3 analysts providing estimates, indicating this is a less-followed mid-cap name where limited institutional interest can contribute to higher volatility and less efficient price discovery. The average revenue estimate for the coming period is $3.96 billion, with a tight range between $3.93 billion and $4.00 billion, suggesting analysts have relatively high conviction on the top-line outlook despite the low coverage count. The recent institutional rating actions show a mixed but generally stable picture, with JP Morgan downgrading to Neutral from Overweight in March 2026, while Stifel upgraded to Buy from Hold in November 2025, reflecting ongoing debate about the stock's trajectory post the Hawthorne divestiture and debt reduction efforts.
Bulls vs Bears: SMG Investment Factors
The bull and bear cases for SMG are sharply defined by the tension between its strong operational cash generation and its perilous balance sheet. The bull side has stronger near-term evidence, anchored by the company's $358 million TTM free cash flow, dominant brands, and a strategic refocus that simplifies the story. However, the bear case presents a severe structural risk via the highly leveraged balance sheet (Debt/Equity of -6.66) that cannot be ignored. The single most important factor in the investment debate is the company's ability to use its seasonal cash flows to materially reduce debt over the next 12-18 months. Success here would validate the bull thesis and re-rate the stock; failure would amplify financial risk and likely trigger a significant de-rating.
Bullish
- Strong TTM Free Cash Flow: The company generated $358.1 million in trailing twelve-month free cash flow, providing crucial internal funding to service its high debt load and invest in the business. This robust cash generation, despite seasonal losses, underpins financial stability and strategic flexibility.
- Strategic Refocus on Core Business: The recent divestiture of the Hawthorne Gardening subsidiary signals a clear strategic pivot back to the dominant consumer lawn and garden segment. This simplification should improve operational focus and could lead to margin improvement and debt reduction.
- Attractive Forward Valuation: With a forward P/E of 14.2x, the stock is pricing in a significant earnings recovery from the trailing P/E of 22.6x. This forward multiple appears reasonable for a market-leading, cyclical franchise if earnings normalize as expected.
- Dominant Market Position & Brands: SMG holds a leading position in the North American consumer lawn and garden market with iconic brands like Scotts, Miracle-Gro, and Ortho. This brand equity provides pricing power and a durable competitive moat in its core business.
Bearish
- Highly Leveraged, Weak Balance Sheet: The balance sheet carries extreme financial risk with a negative debt-to-equity ratio of -6.66 and a negative Return on Equity of -40.6%. This indicates significant accumulated deficits and a heavy reliance on debt financing.
- Deeply Cyclical & Seasonal Losses: The company posts substantial losses in its off-season quarters, with a Q1 2026 net loss of $125 million and a 15% YoY revenue decline. This inherent volatility complicates valuation and creates earnings risk if the peak season underperforms.
- High Volatility & Recent Underperformance: The stock's beta of 1.924 indicates it is 92% more volatile than the market. It has recently underperformed the S&P 500 by 9.39 percentage points over the past month, showing vulnerability during market pullbacks after a strong run.
- Limited Analyst Coverage & Sentiment: With only 3 analysts providing estimates, SMG is a less-followed name, which can lead to higher volatility and less efficient price discovery. Recent rating actions are mixed, reflecting ongoing debate about the post-divestiture trajectory.
SMG Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 25.40% one-year price appreciation. As of the latest close at $67.20, the stock is trading at approximately 93% of its 52-week high of $72.35, positioning it near the upper bounds of its annual range, which suggests strong momentum but also raises concerns about potential overextension. Recent momentum shows a short-term divergence from the longer-term uptrend, with the stock down 0.69% over the past month, underperforming the S&P 500 by 9.39 percentage points, indicating a period of consolidation or profit-taking after the strong run. The stock's high beta of 1.924 signals it is roughly 92% more volatile than the broader market, which is a critical factor for risk management, especially given its recent pullback from the $70 resistance level toward the $60 support area defined by the March lows.
Beta
1.92
1.92x market volatility
Max Drawdown
-25.3%
Largest decline past year
52-Week Range
$46-$72
Price range past year
Annual Return
+21.7%
Cumulative gain past year
| Period | SMG Return | S&P 500 |
|---|---|---|
| 1m | +7.8% | +12.2% |
| 3m | +4.1% | +2.3% |
| 6m | +23.1% | +4.7% |
| 1y | +21.7% | +29.2% |
| ytd | +10.0% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SMG Fundamental Analysis
Revenue growth is highly seasonal and currently in a contraction phase for the off-season quarter, with Q1 2026 revenue of $354.4 million representing a 15% year-over-year decline. The multi-quarter trend shows the business is cyclical, with strong profitability in the spring and summer quarters (Q2 and Q3) offset by losses in the fall and winter, as evidenced by Q3 2025 revenue of $1.188 billion and net income of $149.1 million versus the recent Q1 2026 net loss of $125 million. Profitability is deeply cyclical, with the company posting a net loss of $125 million and a gross margin of 25.0% in the most recent Q1, a period that is historically weak; however, the trailing twelve-month net margin is positive at 4.25%, indicating the business generates annual profits. The balance sheet carries significant financial risk, with a negative debt-to-equity ratio of -6.66 and a negative Return on Equity of -40.6%, primarily due to accumulated deficits; however, the company generated substantial trailing twelve-month free cash flow of $358.1 million, providing some internal funding capacity to service its high debt load, as reflected in a current ratio of 1.27.
Quarterly Revenue
$354400000.0B
2025-12
Revenue YoY Growth
-0.14%
YoY Comparison
Gross Margin
+0.25%
Latest Quarter
Free Cash Flow
$358099999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SMG Overvalued?
Given the company's positive trailing net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 22.6x and a forward PE of 14.2x, with the significant discount in the forward multiple implying the market anticipates a substantial recovery in earnings over the next twelve months. Compared to sector averages, the trailing PE of 22.6x is difficult to contextualize without a specific industry benchmark, but the forward PE of 14.2x appears reasonable for a company with a cyclical, market-leading franchise, assuming earnings normalization. Historically, the stock's own valuation has been volatile, with the current trailing PE of 22.6x sitting well below the extreme highs seen in recent years (e.g., over 20x in 2021) but above the deeply negative multiples posted during loss-making quarters, suggesting the market is pricing in a recovery but not peak-cycle optimism.
PE
22.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -45x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute and center on the company's leveraged capital structure. The negative debt-to-equity ratio of -6.66 and negative ROE of -40.6% signal a balance sheet burdened by accumulated deficits. While TTM free cash flow of $358.1 million provides a cushion, the business model's deep seasonality—evidenced by a Q1 2026 net loss of $125 million—creates cash flow timing mismatches that complicate debt servicing. Revenue is also highly concentrated in the North American consumer lawn and garden market, making it vulnerable to regional weather patterns and economic cycles.
Market & Competitive Risks include the stock's high volatility (beta of 1.924) and its recent trading near the upper bounds of its 52-week range at 93% of its $72.35 high. This positioning, combined with a forward P/E of 14.2x that assumes a perfect earnings recovery, leaves the stock exposed to valuation compression if growth disappoints. Competitive and regulatory pressures on core products (e.g., herbicides) are persistent sector headwinds. The limited analyst coverage (only 3 analysts) exacerbates these risks by contributing to potentially inefficient price discovery and lower liquidity.
Worst-Case Scenario involves a combination of a poor spring/summer selling season due to unfavorable weather or consumer pullback, leading to an earnings miss. This would strain cash flow needed for debt service, potentially triggering covenant concerns or a credit rating downgrade. Concurrently, the high beta would amplify a general market downturn. This chain of events could realistically drive the stock back to its 52-week low of $45.61, representing a downside of approximately -32% from the current price of $67.20. The stock's historical max drawdown of -25.26% over the provided period shows it is capable of such sharp declines.